CVE-2023-40493

LG Simple Editor copySessionFolder Directory Traversal Remote Code Execution Vulnerability

Description

LG Simple Editor copySessionFolder Directory Traversal Remote Code Execution Vulnerability. This vulnerability allows remote attackers to execute arbitrary code on affected installations of LG Simple Editor. Authentication is not required to exploit this vulnerability. The specific flaw exists within the implementation of the copySessionFolder command. The issue results from the lack of proper validation of a user-supplied path prior to using it in file operations. An attacker can leverage this vulnerability to execute code in the context of SYSTEM. . Was ZDI-CAN-19920.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 3.0 •
EPSS 1.47% Top 25%
Third-Party Advisory zerodayinitiative.com
Affected: LG Simple Editor
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-40493?
CVE-2023-40493 has been scored as a critical severity vulnerability.
How to fix CVE-2023-40493?
To fix CVE-2023-40493, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-40493 being actively exploited in the wild?
It is possible that CVE-2023-40493 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-40493?
CVE-2023-40493 affects LG Simple Editor.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.